Daniel Andrew Okin, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Paralysis | 1 | 2021 | 31 | 0.810 |
Why?
|
| Mevalonic Acid | 1 | 2016 | 42 | 0.550 |
Why?
|
| Biosynthetic Pathways | 1 | 2016 | 137 | 0.520 |
Why?
|
| Hepatitis | 1 | 2016 | 227 | 0.480 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1368 | 0.290 |
Why?
|
| Biological Evolution | 1 | 2012 | 1074 | 0.280 |
Why?
|
| Prone Position | 1 | 2022 | 194 | 0.200 |
Why?
|
| Neoplasms | 4 | 2023 | 21596 | 0.200 |
Why?
|
| Diaphragm | 1 | 2021 | 347 | 0.180 |
Why?
|
| Inflammation | 2 | 2023 | 10578 | 0.170 |
Why?
|
| Inflammasomes | 1 | 2023 | 493 | 0.160 |
Why?
|
| Edema | 1 | 2022 | 790 | 0.160 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2016 | 30 | 0.140 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 457 | 0.140 |
Why?
|
| Protein Prenylation | 1 | 2016 | 73 | 0.140 |
Why?
|
| Mice, Obese | 1 | 2016 | 424 | 0.130 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 279 | 0.120 |
Why?
|
| Dyspnea | 1 | 2021 | 1298 | 0.120 |
Why?
|
| Immunocompetence | 1 | 2013 | 137 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2021 | 807 | 0.110 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2013 | 135 | 0.100 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 2566 | 0.100 |
Why?
|
| Renal Dialysis | 1 | 2020 | 1780 | 0.090 |
Why?
|
| ras Proteins | 1 | 2016 | 1060 | 0.090 |
Why?
|
| Fasting | 1 | 2016 | 1589 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2020 | 1472 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2211 | 0.080 |
Why?
|
| Triglycerides | 1 | 2016 | 2450 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 2536 | 0.070 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2006 | 52 | 0.070 |
Why?
|
| Blood Coagulation | 1 | 2012 | 1126 | 0.070 |
Why?
|
| Environment | 1 | 2012 | 1115 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2021 | 4414 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2006 | 223 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 1310 | 0.070 |
Why?
|
| Paracrine Communication | 1 | 2006 | 276 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2077 | 0.060 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2003 | 117 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 9826 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 7721 | 0.050 |
Why?
|
| Humans | 13 | 2023 | 742088 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2016 | 6249 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2022 | 77098 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2003 | 471 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2012 | 2956 | 0.050 |
Why?
|
| Metagenome | 1 | 2023 | 417 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 686 | 0.040 |
Why?
|
| Adrenal Gland Diseases | 1 | 2020 | 138 | 0.040 |
Why?
|
| Urogenital Neoplasms | 1 | 2020 | 135 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 2513 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 1636 | 0.040 |
Why?
|
| Myositis | 1 | 2020 | 251 | 0.040 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2020 | 299 | 0.030 |
Why?
|
| Middle Aged | 5 | 2021 | 213127 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 2020 | 659 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2003 | 2968 | 0.030 |
Why?
|
| Female | 6 | 2021 | 379592 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 57683 | 0.030 |
Why?
|
| Myocarditis | 1 | 2020 | 770 | 0.030 |
Why?
|
| Mice | 2 | 2016 | 81045 | 0.020 |
Why?
|
| Inpatients | 1 | 2021 | 2495 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11470 | 0.020 |
Why?
|
| Pneumonia | 1 | 2020 | 2117 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8662 | 0.020 |
Why?
|
| Aged | 5 | 2021 | 162944 | 0.020 |
Why?
|
| Animals | 3 | 2016 | 168561 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2006 | 244 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2020 | 2712 | 0.020 |
Why?
|
| Male | 6 | 2021 | 349538 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2006 | 351 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2006 | 379 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 62966 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 625 | 0.010 |
Why?
|
| Mutation | 2 | 2003 | 29717 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 438 | 0.010 |
Why?
|
| Melanoma | 1 | 2020 | 5462 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 1160 | 0.010 |
Why?
|
| Hospitalization | 1 | 2021 | 10232 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5662 | 0.010 |
Why?
|
| Introns | 1 | 2003 | 991 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 2049 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2003 | 608 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 3293 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 1263 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40450 | 0.010 |
Why?
|
| Exons | 1 | 2003 | 2431 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 2699 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13019 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 5892 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 3563 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 5454 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 4328 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2006 | 23387 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 19223 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 18112 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11363 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2003 | 2746 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2003 | 4566 | 0.000 |
Why?
|
| Adolescent | 1 | 2003 | 85649 | 0.000 |
Why?
|
| Adult | 1 | 2003 | 213712 | 0.000 |
Why?
|